
Fructo-oligosaccharides are soluble dietary fibers that are not digested in the small intestine and serve as food for beneficial bifidobacteria in the colon.
What is it
FOS (fructo-oligosaccharides) are short chains of fructose units, a shorter form of inulin. The digestive system does not break them down in the small intestine, so they reach the colon as dietary fiber. There they serve as an energy source for bacteria, which is why they are classified as prebiotics: a food substance that promotes the growth of beneficial bacteria.
Source
FOS are found naturally in artichoke, chicory, onion, leek, garlic and asparagus, and in smaller amounts in grains. The highest concentration is found in the yacon tuber. Commercially they are produced in two ways: partial breakdown of inulin using enzymes, or synthesis from ordinary sugar using fungal enzymes.
How it works
Bifidobacterium bacteria have an enzyme especially suited to breaking the bonds in FOS, so they use it efficiently. In laboratory studies, FOS was found to selectively promote the growth of bifidobacteria while keeping levels of potentially harmful bacteria low.
What the research says
A 2022 meta-analysis of eight randomized controlled trials found:
- A significant increase in the number of Bifidobacterium bacteria while taking FOS, with a greater effect in adults than in infants.
- A trend toward a stronger effect at doses above 5 grams a day and with use for more than four weeks, although the difference was not statistically significant.
- No change was found in the number of Lactobacillus bacteria.
The researchers note that the number of studies is small, measurement methods differed and publication bias is possible. In addition, a 2024 meta-analysis of 17 randomized trials (713 participants) found that FOS increased stool frequency, softened stools and reduced straining in people with constipation, but the variability between the studies was large and the researchers expressed "cautious optimism". In other words, the effect on gut bacteria and on constipation is supported by research, but the optimal dose and duration of use have not yet been established.
Safety
In the meta-analysis, FOS was found to be well tolerated, and no significant increase in bloating, gas or abdominal pain was found compared with control groups. However, in the constipation meta-analysis mild bloating was the main side effect, and because of its rapid fermentation in the gut it may cause bloating and gas, especially at the start of use. No serious side effects were reported. It is advisable to start with a low dose and increase gradually.